Insider · CIK 0001521111
Gary Hattersley
officer
Files at NUVB (Nuvation Bio Inc.). First filing Oct 29, 2025, latest Nov 24, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $3.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NUVB: Nuvation Bio Inc.
NUVBOct 9, 2026 · close 5.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Nuvation Bio Inc. | $2.7M 369,051 shares | -534% | +322% from low-2% from high | |
| 18Weak | Nuvation Bio Inc. | $502k 100,000 shares | -100% | +204% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +748,130 | $0.00 | $0 | 748,130 | Mar 3, 2026 |
| Nov 20, 2025 | NUVB Nuvation Bio Inc. | MOption exercise Class A Common Stock | +69,051 | $1.74 | $120k | 69,051 | Nov 24, 2025 |
| Nov 20, 2025 | NUVB Nuvation Bio Inc. | SOpen-market sale Class A Common Stock | -69,051 | $7.23 | $499k | 0 | Nov 24, 2025 |
| Nov 20, 2025 | NUVB Nuvation Bio Inc. | MOption exercise Class A Common Stock | +300,000 | $1.94 | $582k | 300,000 | Nov 24, 2025 |
| Nov 20, 2025 | NUVB Nuvation Bio Inc. | SOpen-market sale Class A Common Stock | -300,000 | $7.23 | $2.2M | 0 | Nov 24, 2025 |
| Nov 20, 2025 | NUVB Nuvation Bio Inc. | MOption exercise Stock Option (Right to Buy)derivative | -69,051 | $0.00 | $0 | 229,884 | Nov 24, 2025 |
| Nov 20, 2025 | NUVB Nuvation Bio Inc. | MOption exercise Stock Option (Right to Buy)derivative | -300,000 | $0.00 | $0 | 200,000 | Nov 24, 2025 |
| Oct 27, 2025 | NUVB Nuvation Bio Inc. | MOption exercise Class A Common Stock10b5-1 | +100,000 | $1.74 | $174k | 100,000 | Oct 29, 2025 |
| Oct 27, 2025 | NUVB Nuvation Bio Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $5.02 | $502k | 0 | Oct 29, 2025 |
| Oct 27, 2025 | NUVB Nuvation Bio Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -100,000 | $0.00 | $0 | 298,935 | Oct 29, 2025 |
| Feb 28, 2025 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.